Frequently Asked Questions
The TM Flow device offers numerous benefits for medical practices, including non-invasive and accurate testing, early detection of autonomic and arterial dysfunctions, and comprehensive diagnostics that reduce the overall cost of patient care. Additionally, the device’s tests are easy to bill with multi-code diagnostics, making it a valuable investment for enhancing patient care and optimizing practice efficiency. It also supports compliance with standards of care recommended by leading health organizations.
Yes, the TM Flow device is covered by Medicare and most private pay carriers. Specific CPT codes, such as 95921 for cardiovagal innervation and 93923 for ankle-brachial pressure index, ensure that the diagnostics are easy to bill. Coverage and reimbursements may vary depending on the Medicare locality, but the comprehensive diagnostics offered by the TM Flow device are widely recognized and supported by insurance providers.
Autonomic nervous system testing is crucial for diabetes and cardiovascular patients because it helps in the early detection of autonomic neuropathy, which is a common complication in these conditions. Early detection through ANS testing allows for timely intervention and management, reducing the risk of further complications. The American Diabetes Association recommends ANS testing as a standard of care for patients with Type 1 and Type 2 diabetes, highlighting its importance in effective diabetes management.
The TM Flow device is an advanced, non-invasive diagnostic tool designed to perform a series of tests that aid in the identification and early detection of autonomic nervous system (ANS) and arterial dysfunctions. It provides quantitative assessments of the ANS, helping to distinguish between early and late stages of autonomic neuropathy. The TM Flow device is particularly valuable for cardiovascular and diabetic autonomic neuropathy (DAN) testing, making it an essential tool in diabetes management and cardiovascular assessments.
TM Flow in Baton Rouge
The TM Flow test is a novel, non-invasive system that helps physicians in Baton Rouge, LA quickly diagnose many forms of neuropathy. The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions. It will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease. The TM Flow system is easy to use and can be performed on an outpatient basis at any accredited laboratory facility in the United States.
The TM Flow system is a novel, non-invasive test for quickly diagnosing the nature and severity of Peripheral Neuropathy.
The TM Flow test is a non-invasive, single-use system that quickly diagnoses the nature and severity of Peripheral Neuropathy. The system is FDA approved and reimbursed by Medicare and many private insurance plans.
It will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease.
TM Flow is a non-invasive test for quickly diagnosing the nature and severity of Peripheral Neuropathy. This includes diabetic neuropathy and peripheral arterial disease, which are both common conditions that affect patients in Baton Rouge, LA.
With TM Flow, physicians in Baton Rouge can find one of the earliest signs of diabetic neuropathy and peripheral arterial disease. In addition to being useful in diagnosing these conditions, it will also help them determine if you have other forms of neuropathy that need attention such as Guillain Barre Syndrome or Carpal Tunnel Syndrome.
The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions.
The TM Flow system is highly sensitive at detecting both large fiber and small fiber neuropathies, as well as more than a dozen other conditions. The test can detect many conditions that cause neuropathy, including diabetes and peripheral arterial disease.
TM Flow testing is reimbursable by Medicare and many private insurance plans.
TM Flow testing is reimbursable by Medicare, most private insurance plans, and Medicaid.
- Medicare will reimburse for this test.
- Most private insurance plans will reimburse for this test.
- Medicaid will reimburse for this test.
An easy 15-minute test can diagnose most forms of neuropathy quickly and accurately.
The TM Flow test is a non-invasive, easy 15-minute test that can diagnose most forms of neuropathy quickly and accurately. The test is reimbursable by Medicare and many private insurance plans.
Conclusion
The TM Flow test is a simple and cost-effective way to diagnose many forms of neuropathy quickly and accurately. The test is safe, painless, noninvasive and can be performed in-office with no sedation required. It uses a patient’s own feet as the testing tool instead of needles or electrodes placed on the skin. We are excited about this new test because it will help physicians in Baton Rouge, LA find one of the earliest signs of diabetic neuropathy and peripheral arterial disease so they can begin treatment sooner than ever before!
RSS FEED
- The TM Flow is a highly reimbursable diagnostic in Portland, OR
- Pain Clinics in Albuquerque, NM Adopt the TM Flow as Gold Standard
- Neuropathy in Philadelphia, PA can be detected with the TM Flow device
- Pain Management Clinics in Dallas, TX are Using the TM Flow to Diagnose Symptoms
- Unlocking the Potential of ANS Testing: Insights for Healthcare Providers
- Neuropathy clinics in Savanah, GA use the TM Flow
- Come to Charleston, WV to Get a TM Flow
- How the TM Flow will maximize your physician practice in Boise Idaho
- Doctors in Pittsburg, PA are using the TM Flow for the treatment of neuropathy
- Which Patients Require ANS Testing?
